CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Siponimod Effective, Safe in Secondary Progressive MS

Published: Mon, 26 Jun 2017 07:49:06 EDT
EXPAND trial results show that the selective S1P receptor modulator reduced the risk for confirmed disability progression by 21% at 3 months and 26% at 6 months and was safe.
Medscape Medical News

EMA Panel Likes Breast and Kidney Cancer Drugs

Published: Mon, 26 Jun 2017 05:27:17 EDT
The Committee for Medicinal Products for Human Use recommended approval of ribociclib for advanced HER+/HER2- breast cancer and tivozanib for advanced renal cell carcinoma.
International Approvals

Modifiable Risk Factors and Preoperative Optimization in THA

Published: Mon, 26 Jun 2017 12:00:00 EDT
An understanding of the modifiable preoperative risk factors will help reduce the risk of complications and optimize outcomes in total hip arthroplasty.
Current Orthopaedic Practice
Displaying results 10-12 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Seven years after Merck deal, ElexoPharm offloads aldosterone synthase inhibitors to Angion

Published: Thu, 22 Jun 2017 12:19:15 +0000
ElexoPharm has licensed inhibitors of the aldosterone synthase enzyme to Angion Biomedica. The exclusive pact comes seven years after ElexoPharm struck a deal granting Merck rights to drugs against the same target.

Eli Lilly completes expansion of San Diego biotech center

Published: Thu, 22 Jun 2017 09:54:06 +0000
Eli Lilly has completed the expansion of its biotech facility in San Diego, California. The Big Pharma has more than doubled the size of the West Coast site and installed an automated, remote-controlled drug design and testing studio. 

Celgene-backed cancer biotech Repare emerges from stealth with $68M

Published: Thu, 22 Jun 2017 08:16:06 +0000
After 18 months being incubated by Versant Ventures, upstart Repare Therapeutics has emerged from stealth mode with an impressive $68 million.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top